RALA and prostate carcinoma: Notably, in the PC-3 cell model, Wang et al. demonstrated that decreased RALA activity impedes the proliferation, migration, and invasion of PC3 cells, which aligns with our findings and hints at RALA potentially serving as a poor prognostic factor in prostate cancer (PCa) (WANG et al. 2015).